ACTINIUM PHARMACEUTICALS
Actinium Pharmaceuticals provides biopharmaceutical, radiotherapies, medical research, development, and clinical trial services.
ACTINIUM PHARMACEUTICALS
Industry:
Biotechnology Clinical Trials Health Diagnostics Pharmaceutical
Founded:
2000-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.actiniumpharma.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Similar Organizations
BioSciences Research Associates
BioSciences Research Associates provides laboratory services for product development and clinical trials to pharmaceutical companies.
Canam Bioresearch
Canam Bioresearch is a biotechnology pharmaceutical company located in Winnipeg.
Clinical Research Associates
Clinical Research Associates is a research firm that provides research and clinical trials services.
ClinSmart
ClinSmart is a clinical research organization that specializes in drug safety, regulatory, medical trials, and biostatistics services.
IBEX Preclinical Research
IBEX Preclinical Research provides neurosurgical modeling, soft tissue surgery, drug development, and pre-clinical research services.
Seattle Allergy & Asthma Research Institute
Seattle Allergy & Asthma Research Institute researches allergies and asthma and helps pharmaceutical companies in medicinal developments.
Spear Products
Spear Products is a providers of biological raw materials for research, pharmaceutical, and medical manufacturing companies.
Waife & Associates
Waife & Associates focuses on pharmaceutical, medical, biostatics, clinical research and drug development services.
Current Employees Featured
Investors List
National Institutes of Health
National Institutes of Health investment in Grant - Actinium Pharmaceuticals
Key Employee Changes
Date | New article |
---|---|
2022-11-02 | Actinium Appoints Seasoned Leader Caroline Yarbrough as Chief Commercial Officer to Spearhead Iomab-B Commercialization |
Official Site Inspections
http://www.actiniumpharma.com Semrush global rank: 4.4 M Semrush visits lastest month: 2.22 K
- Host name: ec2-174-129-30-187.compute-1.amazonaws.com
- IP address: 174.129.30.187
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Actinium Pharmaceuticals"
Profile :: Actinium Pharmaceuticals, Inc. (ATNM)
Actinium Pharmaceuticals, Inc. (NYSE MKT:ATNM) is a publicly traded, late-stage biopharmaceutical company, leading the development of targeted radiotherapies to โฆSee details»
Management Team :: Actinium Pharmaceuticals, Inc. (ATNM)
Jenny has nearly two decades of experience in leading and developing corporate strategies across the healthcare and life sciences industries. Prior to joining Actinium, Jenny was the โฆSee details»
About :: Actinium Pharmaceuticals, Inc. (ATNM)
Actinium Pharmaceuticals, Inc. is a late-stage biopharmaceutical company developing targeted radiotherapies to meaningfully improve survival for people who have failed existing oncology โฆSee details»
Actinium Pharmaceuticals - Overview, News & Similar ... - ZoomInfo
View Actinium Pharmaceuticals (www.actiniumpharma.com) location in New York, United States , revenue, industry and description. Find related and similar companies as well as employees โฆSee details»
Actinium Pharmaceuticals - Crunchbase Company โฆ
Organization. Actinium Pharmaceuticals . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Contact Email [email protected]; Lists Featuring This Company. โฆSee details»
Investor Relations :: Actinium Pharmaceuticals, Inc.
Actinium Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing targeted radiotherapies to deliver cancer-killing radiation with cellular level precision to treat patients with high unmet needs not addressed by โฆSee details»
Actinium Pharmaceuticals Appoints Accomplished Biopharma โฆ
Nov 4, 2024 She was a Vice President in the Clinical Safety Organization, chaired a PhRMA-FDA working group, and worked in the area of scientific licensing. She also led the โฆSee details»
Actinium Pharmaceuticals, Inc. โ (ATNM)
Actinium is developing a pipeline of Antibody Radiation Conjugates for targeted conditioning and combination therapies The Pivotal Phase 3 SIERRA Trial for Iomab-B is 100% Enrolled.See details»
Actinium Provides Regulatory Update on Planned BLA Filing and โฆ
Aug 5, 2024 Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) ("Actinium" or the "Company"), a leader in the development of Antibody Radiation Conjugates ("ARCs") and โฆSee details»
Actinium Expands Clinical Leadership Team to Support Key โฆ
Oct 27, 2022 Actinium Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing targeted radiotherapies to deliver cancer-killing radiation with cellular level โฆSee details»
Actinium Pharmaceuticals Launches Actinium-225 Focused โฆ
Mar 11, 2024 Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or the Company), a leader in the development of Antibody-Radio Conjugates (ARCs) and other โฆSee details»
Partners :: Actinium Pharmaceuticals, Inc. (ATNM)
Actinium has forged strong partnerships with companies globally who share our vision of bringing targeted radiotherapies to patients in need.See details»
Actinium Pharmaceuticals, Inc. (ATNM) Stock Price, News, Quote ...
Actinium Pharmaceuticals, Inc. develops antibody radiation conjugates and other targeted radiotherapies intended to improve outcomes for people who have failed existing oncology โฆSee details»
Actinium Bolsters its Senior Leadership Team Ahead of Upcoming โฆ
Oct 25, 2022 Actinium Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing targeted radiotherapies to deliver cancer-killing radiation with cellular level โฆSee details»
Working at Actinium Pharmaceuticals - Zippia
Mar 14, 2024 Actinium Pharmaceuticals, Inc., a biopharmaceutical company, engages in developing therapies for life threatening diseases using its alpha particle immunotherapy โฆSee details»
Actinium Pharmaceuticals Announces New Hires As Supply Chain ...
Actinium Pharmaceuticals, Inc. ( www.actiniumpharma.com) is a New York-based biopharmaceutical company developing innovative targeted payload immunotherapeutics for โฆSee details»
Actinium Announces Multiple Senior Leadership Appointments โฆ
Actinium Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing targeted radiotherapies to deliver cancer-killing radiation with cellular level precision to treat patients โฆSee details»
Actimab-A :: Actinium Pharmaceuticals, Inc. (ATNM)
Bone Marrow Transplant Induction and Conditioning in One. Iomab-B, Actiniumโs lead asset, is being studied in the pivotal Phase 3 SIERRA clinical trial as an induction and conditioning โฆSee details»
Actinium Pharmaceuticals Reports 2022 Financial Results and โฆ
Apr 3, 2023 Actinium Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing targeted radiotherapies to deliver cancer-killing radiation with cellular level โฆSee details»